Europe has set the stage for safer supply chains with its Falsified Medicines Directive. Next, the spotlight could fall on using serialization to boost patient centricity.

Amazing innovation is happening all around us in the pharma industry. We should take the time to look outside of our own unique areas to congratulate the efforts of others.

Will future drugs in Europe be priced based on therapeutic outcomes?

Will expanding the Priority Review Voucher scheme defeat its original purpose?

How difficult is it to develop a new drug? Statistics have the answer

The EMA says it will review its standards for first-in-human trials

A survey-based report highlights wildly inaccurate drug demand projections

Tumor cells and phages inspire a new drug delivery method targeting the placenta

Cell therapy successes are widely hailed as breakthroughs, but will adverse effects and patient deaths hold the field back?

Automated image analysis has been combined with Raman spectroscopy to achieve component-specific size and shape analysis of active ingredients, supporting and accelerating the commercialization of both innovator and generic pharmaceutical products.